Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: 5-hydroxytryptamine 2B antagonists - AnaMar AB

Next Previous
Drug Profile

Research programme: 5-hydroxytryptamine 2B antagonists - AnaMar AB

Alternative Names: 5-HT2B; 5-HT2B receptor antagonist; 5-Hydroxytryptamine 2B Receptor Antagonist; AM-1125

Latest Information Update: 28 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AnaMar AB
  • Class Antifibrotics; Skin disorder therapies; Small molecules
  • Mechanism of Action Serotonin 2B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Idiopathic pulmonary fibrosis; Systemic scleroderma

Most Recent Events

  • 28 Mar 2021 No recent reports of development identified for research development in Idiopathic-pulmonary-fibrosis in Sweden
  • 28 Dec 2020 No recent reports of development identified for research development in Systemic-scleroderma in Sweden (PO)
  • 21 Feb 2017 Research programme: 5-hydroxytryptamine 2B - AnaMar AB is available for licensing as of 21 Feb 2017. http://anamar.com/rd/partners-collaborators/

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top